Semaglutide (Ozempic, Wegovy, Rybelsus) is a GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management
It is essential to note that tirzepatide has no FDA-approved indication for treating substance use disorders
Hormone Evaluation (Optional) For patients struggling with fatigue, slow metabolism, or weight gain, hormone optimization can dramatically improve results
The BBL presents a horrendous risk
In its research-grade form, it appears as a white to off-white lyophilized powder that dissolves readily in water
Potential Differences in Effectiveness Due to the differences in how they are absorbed, sublingual and injectable semaglutide may not have the exact same effectiveness for every individual